ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) last traded at $75.35, down 2.55% on the session. The quote above updates while this page is open; the figures below are drawn from ANI Pharmaceuticals, Inc.’s own filings and are restated only when a new one is published.
ANI Pharmaceuticals, Inc. trades on NASDAQ under the ticker ANIP. Its market capitalisation is $1.69 billion.
Valuation measures for ANI Pharmaceuticals, Inc., derived from the latest quote and its most recent SEC filing.
| Market cap | $1.69B |
|---|---|
| Enterprise value | $2.23B |
| P/E ratio | 16.38 |
| Price / sales | 1.73 |
| Price / book | 2.84 |
| Beta | 0.24 |
Trailing-twelve-month figures tagged in ANI Pharmaceuticals, Inc.'s XBRL filings with the SEC.
| Revenue (TTM) | $978.38M |
|---|---|
| Net income (TTM) | $108.31M |
| EPS (TTM) | $4.60 |
| Operating margin | 15.37% |
| Return on equity | 18.14% |
| Cash | $360.21M |
Range and volume for ANIP over the past 52 weeks.
| 52-week high | $99.50 |
|---|---|
| 52-week low | $70.15 |
| Volume | 318.2K |
| Average volume | 338.2K |
| Previous close | $77.32 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.